Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Cancer Immunol Res. 2023 Sep 1;11(9):1168–1183. doi: 10.1158/2326-6066.CIR-22-0465

Figure 7. ERK5 S496A KI alters tumor growth and shifts TAM phenotype differently than with exercise.

Figure 7.

YUMMER tumor–bearing mice performed approximately two weeks of treadmill exercise (Exer) or were non-exercised sedentary controls (Sed). A) Immunofluorescent images of F4/80 (marker for TAMs; green), phospho-ERK5 S496 (cyan), and DAPI (blue) on YUMMER tumors, representative of >5 microscopic fields per tumor and 7 –10 tumors per group; scale bar: 100μm. B) Quantification of percent of phospho-ERK5 S496+F4/80+ area in YUMMER tumors from sedentary or exercised mice. Graphs are displayed with mean +/− standard error of the mean (SEM); each point represents one tumor value obtained by the average of ≥ 5 10x microscopic fields. C) YUMMER tumor volume in ERK5 WT (C57Bl/6) mice and ERK5 S496A KI mice was monitored with calipers. Tumor growth curves were analyzed using two-way ANOVA (Time v ERK5S496A: p=0.0122; Time: p<0.0001; Exercise: p=0.0.2119) with post-hoc multiple comparisons displayed on graphs. ns= p > 0.05, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Flow cytometry quantification of the percent of D) F4/80+ TAMs relative to CD11b+Gr1 cells, E) CD206+iNOS TAMs relative to CD11b+Gr1F4/80+ cells, F) CD206 MFI in CD11b+Gr1F4/80+ cells, G) iNOS+CD206 TAMs relative to CD11b+Gr1F4/80+ cells, H) iNOS MFI in CD11b+Gr1F4/80+ cells. I) YUMMER tumor volume in sedentary or exercised ERK5 S496A KI mice was monitored with calipers. Tumor growth curves were analyzed using two-way ANOVA (Time v Exercise: p<0.0001; Time: p<0.0001; Exercise: p=0.0061) with post-hoc multiple comparisons displayed on graphs. ns= p > 0.05, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Flow cytometry quantification of the percent of J) F4/80+ TAMs relative to CD11b+Gr1 cells, K) CD206+iNOS TAMs relative to CD11b+Gr1F4/80+ cells, L) CD206 MFI in CD11b+Gr1F4/80+ cells, M) iNOS+CD206 TAMs relative to CD11b+Gr1F4/80+ cells, N) iNOS MFI in CD11b+Gr1F4/80+ cells. Mouse experiments utilizing ERK5 S496A KI mice were independently repeated two times. Each point on a graph represents one tumor analyzed.